Applying Systems Thinking to Regenerative Medicine Proceedings of a Workshop (2021) / Chapter Skim
Currently Skimming:
Appendix B: Speaker Biographical Sketches
Appendix B: Speaker Biographical Sketches
Pages 137-148
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 137... ...
Abernethy served as the chief medical officer, the chief scientific officer, and the senior vice president for oncology at Flatiron Health (a member of the Roche Group) , where she led the research oncology, clinical operations, and data science teams and contributed to the overall strategic vision of the company, including directing its research vision on real-world evidence.
|
From page 138... ...
Adrian Bot, M.D., Ph.D., is the vice president and the global head of translational medicine at Kite, a Gilead Company, developing genetically engineered cell products for oncology indications.
|
From page 139... ...
Subsequently, he was a guest scientist at the Scripps Research Institute in La Jolla, California. Prior to his appointment as the chief scientific officer at Kite Pharma in 2011 and then the vice president of translational medicine, where he contributed to the development of first-in-class and breakthrough cell therapy products for cancer, Dr.
|
From page 140... ...
Dr. Fertig is an associate professor of oncology and the assistant director of the Research Program in Quantitative Sciences and the associate director of the Convergence Institute at the Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, with secondary appointments in biomedical engineering and applied mathematics and statistics, affiliations in the Institute of Computational Medicine, the Center for Computational Genomics, machine learning, the Mathematical Institute for Data Science, and the Center for Computational Biology.
|
From page 141... ...
Huang held faculty positions at the University of Calgary (Institute of Biocomplexity and Informatics) , where he helped establish biocomplexity as a discipline in research and teaching, and at the Harvard Medical School (Children's Hospital)
|
From page 142... ...
Kotanchek spent 23 years in executive and leadership positions at Dow Chemical, including the vice president for sustainable technologies, innovation sourcing, and information research; the chief technology officer of Dow Chemical China Company Limited; the global business director of Dow Ventures; the global research and development director of Dow Plastics; and the corporate director of materials science and engineering.
|
From page 143... ...
Dr. Lebkowski led Geron's human embryonic stem cell program from 1998–2012 and was responsible for all research, preclinical development, product development, manufacturing, and clinical development activities supporting cell-based therapies for several regenerative medicine indications including spinal cord injury and cardiovascular disease.
|
From page 144... ...
He served as the president of Diagnostic Products Corporation's instrument systems division and as the corporate chief scientific officer prior to its sale to Siemens Health Care.
|
From page 145... ...
Since then, her laboratory has continued to make pioneering contributions to the field of stem cell research by characterizing neural stem cells and the intrinsic and environmental factors that regulate their behavior. Her laboratory's research on the characterization of neural stem and progenitors brings us closer to developing effective clinical treatments for central nervous system damage in which tissue is lost, for example, due to neurodegenerative diseases or trauma.
|
From page 146... ...
NSF's Small Business Innovation Research and Small Business Technology Transfer programs, housed in the Engineering Directorate, support fundamental research being done in high-tech small businesses helping them transition new technologies into the commercial marketplace. A professor at the University of Michigan since 1995, in both mechanical and electrical engineering, Dr.
|
From page 147... ...
From 2017 to 2019 he served as the chair of the National Materials and Manufacturing Board at the National Academies of Sciences, Engineering, and Medicine. In those 3 years the board oversaw several landmark studies, including A Vision for Center-Based Engineering Research, A Quadrennial Review of the National Nanotechnology Initiative, Frontiers of Materials Research: A Decadal Survey, and Strategic Long-Term Participation by DOD in Its Manufacturing USA Institutes.
|
From page 148... ...
He holds an academic appointment as a professor at the University of Toronto's Institute of Biomaterials and Biomedical Engineering. He is the Canada Research Chair in Stem Cell Bioengineering and is a recipient of a number of awards and fellowships including the Premiers Research Excellence Award (2002)
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.